Eucalyptus cypellocarpa
Eucalyptus cypellocarpa · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Eucalyptus cypellocarpa is a distinctive species recognized by its unique botanical characteristics and aromatic properties. The most significant part of this plant utilized for various applications is its versatile leaf. When processed into dried leaves, the plant becomes a valuable resource for traditional and practical uses. These prepared botanical materials retain essential qualities that make them highly sought after. Understanding the specific nature of these dried leaves is crucial for anyone interested in this particular eucalyptus variety.
- Synonyms
- Eucalyptus Pyrenea · Eucalyptus Alaticaulis · 4 more
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Northern America
- Plant Parts
- Leaf
Classification
Common Names
Eucalyptus cypellocarpa is a versatile species known by several distinct common names depending on the region. It is frequently referred to as the Mountain Grey Gum or the Grampians grey-gum. In certain areas, locals may simply call it eucalipto, reflecting its cultural integration. The tree also carries the more whimsical titles of monkey gum and monkey-gum. These various names highlight the widespread recognition of this unique eucalyptus across different landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Eucalyptus cypellocarpa is a botanical taxon that is frequently associated with several different scientific names. Within various taxonomic classifications, this species is recognized by the synonym Eucalyptus alaticaulis. It is also linked to the varieties Eucalyptus goniocalyx var. acuminata and Eucalyptus goniocalyx var. parviflora. Furthermore, the plant shares nomenclatural ties with Eucalyptus oresbia and Eucalyptus pyrenea. Understanding these overlapping synonyms is essential for accurate identification and study within the genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Eucalyptus cypellocarpa is a distinctive species belonging to the kingdom Plantae. Within this vast biological realm, it is specifically classified under the class Equisetopsida. The plant is a member of the order Myrtales, which helps define its structural characteristics. Furthermore, it resides within the Myrtaceae family, a group known for its diverse aromatic properties. Ultimately, this species is defined by its placement in the prominent Eucalyptus genus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Eucalyptus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Eucalyptus cypellocarpa is a notable species primarily found within the Australasia region. Its natural distribution is concentrated throughout the diverse landscapes of Australia. Specifically, this plant can be found growing in the state of New South Wales. It also maintains a significant presence across the territory of Victoria. Together, these locations define the core geographic range of this unique eucalyptus species.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Eucalyptus cypellocarpa is a self-supporting tree that establishes a commanding presence within its ecosystem. This robust species is characterized by its impressive growth form, which allows it to reach significant proportions. In ideal conditions, the tree can attain a maximum height of 65 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Eucalyptus cypellocarpa contains several unique chemical constituents, specifically the newly identified phenol glycosides known as cypellocarpins A, B, and C. These compounds are characterized by being esterified with (+)-oleuropeic acid and were isolated from the plant's dried leaves. Research utilizing spectroscopic methods and 2D NMR experiments has allowed for the precise structural determination of these molecules. Notably, these substances demonstrate significant biological potential due to their potent in vitro antitumor-promoting activity. Furthermore, they have proven effective in suppressing in vivo two-stage carcinogenesis within mouse skin models.
Conditions
Eucalyptus cypellocarpa contains specific phenol glycosides, such as cypellocarpins A-C, that demonstrate significant medicinal potential. These compounds exhibit potent in vitro antitumor-promoting activity by inhibiting Epstein-Barr virus early antigen activation induced by TPA. Furthermore, these substances effectively suppress two-stage carcinogenesis in mouse skin models induced by nitric oxide and TPA. The isolation of these bioactive molecules from the dried leaves highlights the plant's capacity to interfere with specific carcinogenic processes. Through these mechanisms, the plant components act as inhibitors against both viral antigen activation and skin cancer development.
Preparations
Eucalyptus cypellocarpa is prepared as dried leaves for the isolation of specific chemical constituents. These dried leaves serve as the source for three new phenol glycosides known as cypellocarpins A, B, and C. By utilizing the dried leaves, researchers were able to identify these compounds through advanced spectroscopic methods. The extraction from this specific plant preparation allows for the study of their potent antitumor-promoting activity. Consequently, the use of dried Eucalyptus cypellocarpa leaves is essential for discovering compounds that suppress in vivo carcinogenesis.
Parts used
Eucalyptus cypellocarpa serves as a significant botanical source for the discovery of specialized chemical compounds. Researchers have successfully isolated several unique phenol glycosides, known as cypellocarpins A-C, specifically from the plant's dried leaves. These bioactive constituents are esterified with oleuropeic acid and possess notable pharmacological properties. In laboratory settings, these leaf-derived compounds demonstrated potent inhibitory effects against Epstein-Barr virus early antigen activation. Furthermore, they showed promising results in suppressing in vivo two-stage carcinogenesis within mouse skin models.